Hematological Disorders

Download as pdf or txt
Download as pdf or txt
You are on page 1of 45

Hematological disorders in pregnancy

Dr Suhair Qudsieh
Maternal fetal medicine consultant
Yarmouk University
ANAEMIA IN PREGNANCY
Classification of anemia

• Physiological anemia of pregnancy


• Pathological
– Deficiency anemia
• Fe deficiency
• Folic acid deficiency
• Vit B12
• Protein deficeincy
– Haemorrhagic
• Acute – following bleeding in early months or APH
• Chronic – Hookworm infestation, bleeding piles
– Hereditary
• Thalassemias
• Sickle cell haemoglobinopathies
• Other haemoglobinopathies
• Hereditary haemolytic anemias
– Bone marrow insufficiency
– Anemia of infection
– Chronic disease (renal) or neoplasm
Physiological anemia
• In pregnancy:
– Increase in plasma volume, RBC volume and Hb
mass
– Marked demand of extra iron specially in the second
half which cannot be overcome by diet.
• Thus, there always remains a physiological iron
deficiency state during prenancy.
• As a result, there is not only a fall in Hb conc and
hematocrit value in the second half of pregnancy,
but there is also associated low serum iron.
Criteria for physiological anemia

• Hb – 10gm%
• RBC: 3.2 million/mm3
• PCV: 30%
• Peripheral smear: normal morphology of RBC
with central pallor
Degree of anemia

• Hb
• Total Red cell count
• Determination of PCV
Mild Between 8 -10 gm%

Moderate Less than 8 – 7gm%

Severe Less than 7gm%


Type of anemia

• Peripheral blood smear

• Haematological indices: MCHC, MCV and MCH

• Serum iron value


Complication of severe anemia

• During pregnancy:
– Intercurrent infection
– Heart failure
– Preterm labour
• During labour:
– PPH
– Cardiac failure
– Shock
• Puerperium:
– Puerperal sepsis
– Subinvolution
– Failing lactation
Effects on baby:

• LBWt- low birth weight


• Increased incidence Intra uterine death
Prognosis:

• Maternal: if detected early  good


• Fetal: if detected early and responsive to
treatment , good prognosis.
– But in severe and neglected cases, there can be
prematurity
Treatment

• Prophylactic:
– Avoidance of frequent child births
– Supplementary iron therapy
– Dietary prescription
– Adequate treatment
– Early detection of falling Hb level is to be made
• Curative:
– Hospitalisation
– General treatment:
• Diet
• To improve appetite and facilitate digestion
• Effective therapy to cure the disease
Specific therpay:

• Depends on:
– Severity
– Duration of pregnancy
– Assoc complicating factors
Iron therapy

• Oral route:
– Drawbacks:
• Intolerance
• Unpredictable absorption rate
– Response:
• Sense of well being
• Increased appetite
• Improved outlook of the patient
• Haematological examination
• Rise in Hb level
– Improvement is usually within 3
weeks
– Failure:
• Improper typing of anemia
• Defective absorption
• Pt fails to take iron
• Concurrent blood loss
– Contraindication:
• Intolerance
• Severe anemia in advanced pregnancy
• Parenteral therapy:
– Intravenous and Intramuscular
– Indications:
• Contraindications of oral therapy
• Pt not co-operative to take oral iron
• Cases seen for the first time during the last 8 – 10
weeks in severe anemia
• Intravenous route:
– Total dose diffusion: deficit of iron is calculated and
the total amount of iron required is administered by a
single sitting intravenous infusion
– Advantages:
• Eliminates repeated and painful intramuscular
injections
• Treatment completed in a day
• Intramuscular therapy:
– Total dose to be administered is calculated
– After an initial dose of 1ml, the injections are given
daily or on alternate days in doses of 2ml
intramuscularly.
– Drawbacks:
• Painful
• Chance of abscess
• Reactions
• Blood transfusion:
– Limited. But indications are:
• PPH
• Severe anaemia in later months of pregnancy
• Refractory anemia
– Quality and quantity: fresh. Only packed cell. 80 –
100 ml at a time
– Advantages:
• Increased oxygen carrying capacity of the blood
• Hb may be utilised for the formation of new red
cells.
• Stimulated erythropoiesis
• Improvement expected after 3 days
• There is derangement in red cell maturation with the
production in the bone marrow of abnormal
precursors known as megaloblasts due to impaired
DNA synthesis.

• Vit B12 or folate defieciency or both.


• Vit B12 deficiency is rare in pregnancy.
• In pregnancy, due to folic acid deficiency.
Folic acid deficiency…

• Inadequate intake due to:


– Nausea, vomiting, loss of appetite.
– Dietary insufficiency – green leafy veg, cauliflower, spinach,
liver, kidney
• Increased demand:
– Increased maternal tissue including red cell volume.
– Developing product of conception.
• Diminished absorption:
• Abnormal demand:
– Twins, infection, haemorrhagic states.
• Failure of utilisation:
• Anticonvulsant drugs. Diminshed storage:
– Hepatic disorders and vitamin c deficiency.
Incidence

• 0.5 – 3%
• Common in multiparae and multiple
pregnancy.
Haematological examination
and other blood values
• Hb – 10gm%
• Stained blood film: hypersegmentation of the
neutrophils, macrocytosis and anisocytosis.
Megaloblasts.
• MCV- 100 µm3
• MCH –high, MCHC –normal
• Associated leucopenia and thrombocytopenia
• Serum iron is normal or high
• Serum folate – 3ng/ml
• Serum B12 level below <90 pg/ml
• Bone marrow – megaloblastic erythropoiesis
COMPLICATIONS

• Abortion
• Prematurity
• Abruptio placentae
• Fetal malformation
Prophylactic therapy

• All woman of reproductive age should be given


400µg of folic acid daily.
• Additional amount (4mg) should be given where
demand is high.
HAEMOGLOBINOPATHIES
SICKLE CELL ANAEMIA
• Hereditary disorders in which the red cells contain
Hb-S.
• Produced by substitution of valine for glutamic
acid at the position 6 of the β-chain of normal
haemoglobin.
Pathophysiology

• Red cells with HbS in oxygenated state behave


normally but in the deoxygenated state it
aggregates, polymerises and distort the red cells
to sickle.
• These sickle shaped cells block the
microcirculation due to their rigid structure.
Effects on pregnancy

• Increased incidence of abortion,prematurity,


IUGR and fetal loss.
• Perinatal mortality is high.
• Preclampsia, postpartum haemorrahage and
infection is increased.
Effects on the disease.

• There is chance of sickle cell crisis which usually


occurs in the last trimester.
• Haemolytic crisis
• Painful crisis.
Management

• Preconceptional counselling
• During pregnancy: antenatal supervision, regular
blood transfusion at 6 weeks interval is indicated
in certain cases.
• Contraception: sterilisation, oral pill, barrier
method is ideal.
Thalassaemia syndromes

• Commonly found genetic disorders of the blood.


• Basic defect is a reduced rate of globin chain
synthesis.
• As a result, the red cells being formed with an
inadequate haemoglobin content.
• Types – alpha and beta (depending upon the
chain)
Alpha thalassaemia

• Incompatible with life.


• Α-peptide chain production is controlled by 4 genes,
located on chromosome 16. Depending upon the degree
of deficient synthesis – 4 clinical types.
• Mutation of one gene: no clinical or laboratory
abnormalities. Silent carrier
• Mutation in 2 – 4 genes: minor. Often goes
unrecognised and pregnancy is well tolerated.
• Mutation in 3 – 4 genes: Hb H disease. 
hemolytic anaemia.
• Mutation in all four genes: major. No alpha globin
chain. Fetus dies either in utero or soon after birth.
Beta thalassemia

• beta chain production is directed by 2


genes – one on each copy of chromosome
11.
• Major – when mutation affect both the
genes. – red cell destruction- no
erythropoiesis – blood transfusion
necessary for survival.
• Minor – mutation of one gene. – can
tolerate pregnancy –oral folic acid
supplementation is continued.
Thrombocytopenia in
pregnancy
- Gestational thrombocytopenia.
- Pre-eclampsia
- ITP
- TTP
- DIC
- SLE
Idiopathic thrombocytopenic purpura
ITP

• Caused by antibodies to surface antigen on platelets,


leading to platelet destruction.
• Diagnosis is by exclusion of other causes.
• Pregnancy does not affect the disease, but due to a
lower median platelet count in pregnancy usually the
disease worsen in pregnancy.
Fetal risk

• IgG antiplatelet antibodies can cross the placenta


and cause fetal thrombocytopenia .
• Difficult to predict which fetus will be affected(it
has no relation to maternal platelet count.
• Can lead to antenatal and intrapartum intracranial
hemorrhage.
Maternal risk and mangement

• Bleeding is unlikely if platelet count is>50


• Patient with bleeding or platelet count < 50 should be started
on steroid and if there is no adequate response patient will
be offered IV IG.
• Splenectomy is rarely performed in pregnancy.
• Platelet transfusion is required if rapid response is needed.
• In labor avoid:
• Fetal scalp electrodes
• Fetal blood sampling
• Ventouse delivery
• No fetal benefit from C-section.
Gestational thrombocytopenia

• The incidence of gestational thrombocytopenia is


5-11% of all pregnancies and accounts for more
than 70% of cases of thrombocytopenia in
pregnancy.

• The pathophysiology of gestational


thrombocytopenia is unknown, but 2 main factors
are associated with GT.
• -Accelerated platelet activation is suspected to
occur at placental circulation.
• -Accelerated consumption of platelets is due to
the reduced lifespan of platelets during pregnancy.
• Asymptomatic patient with no history of abnormal bleeding
• Mild thrombocytopenia (counts >70,000/μ L)
• Usually detected incidentally on routine prenatal screening
• No specific diagnostic tests to definitively distinguish
gestational thrombocytopenia from mild ITP
• Usually develops in the mid second to third trimester
• Platelet counts normalize within 1-2 months following delivery.
• No pathological significance for the mother or fetus is noted. No
risk for fetal hemorrhage or bleeding complications is observed

You might also like